Related Experiment Video
Updated: May 7, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Homozygous Familial Hypercholesterolemia Treatment: New Developments.
Dirk J Blom1, A David Marais2, Frederick J Raal3
1Division of Lipidology and Cape Heart Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa. dirk.blom@uct.ac.za.
Novel therapies for homozygous familial hypercholesterolaemia (HoFH) offer new ways to lower low-density lipoprotein cholesterol (LDLC). Some treatments depend on receptor function, while others work independently, improving patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
- Genetics
Background:
- Homozygous familial hypercholesterolaemia (HoFH) causes severely high low-density lipoprotein cholesterol (LDLC).
- Patients with HoFH face a high risk of premature atherosclerotic cardiovascular disease.
Purpose of the Study:
- This review examines novel pharmacological therapies for lowering LDLC in HoFH patients.
- Focus on treatments that improve cardiovascular outcomes in HoFH.
Main Methods:
- Review of current literature on emerging pharmacological interventions for HoFH.
- Categorization of therapies based on low-density lipoprotein receptor (LDLR) dependency.
Main Results:
- LDLR-dependent therapies (e.g., PCSK9 inhibitors like alirocumab, evolocumab, inclisiran) show variable efficacy based on residual LDLR function.
- LDLR-independent therapies (e.g., lomitapide, evinacumab, zodasiran) achieve approximately 50% LDLC reduction regardless of LDLR function.
- Combination therapy is often necessary for HoFH patients to reach LDLC targets.
Conclusions:
- Novel LDLR-independent therapies offer significant potential for HoFH management.
- Improved LDLC control may reduce the need for apheresis or liver transplantation.
- These advancements promise a better outlook for patients with HoFH.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Lipid Digestion
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

